1 / 8

Acute Invasive Aspergillosis Treatment Market - Size, Share, Growth and Trends Analysis 2018–2026

Drug resistance to antifungal medications is widely witnessed during treatment of aspergillosis infections, which is expected to restrain growth of the acute invasive aspergillosis treatment market

saairaj
Download Presentation

Acute Invasive Aspergillosis Treatment Market - Size, Share, Growth and Trends Analysis 2018–2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Invasive Aspergillosis Treatment Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017-2025 © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Acute Invasive Aspergillosis Treatment Market – Overview According to the Centers for Disease Control and Prevention, the epidemiology of invasive aspergillus infection is dependent upon increasing number of solid organ transplants, stem cell transplant, and newer immunosuppressive agents, 2017. According to Organ Procurement and Transplantation Network (OPTN), around 8,500 organ transplants have been performed in 2018 and the number is expected to grow in the near future. These factors are expected to support the growth of the acute invasive aspergillosis treatment market. Patients who undergo organ transplant procedure are often prescribed immunosuppressant medications, which increases their susceptibility to aspergillosis infection. Similarly, patients in the advanced stages of AIDS are also highly susceptible to opportunistic infections such as aspergillosis. According to the World Health Organization (WHO), around 36.7 million people were found suffering from HIV in 2016. Extended use of corticosteroids further weakens the immune system, thus increasing the risk of developing such infections. This in turn, is increasing the demand for acute invasive aspergillosis treatment over the forecast period. According to British Infection Association, the high risk population for invasive aspergillosis includes patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT), autologous HSCT patients, solid organ transplant patients as well as AIDS patients, patients suffering from acute myeloid leukaemia, chronic lymphocytic leukaemia, chronic myeloid leukaemia, non-Hodgkin lymphoma, and myeloma patients. According to WHO, Cancer is the second-leading cause of death globally, and the disease caused 8.8 million deaths in 2015. Rising incidence of various types of cancers, is in turn expected to support growth of the global acute invasive aspergillosis treatment market. © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Acute Invasive Aspergillosis Treatment Market Taxonomy: Acute Invasive Aspergillosis Treatment Market Taxonomy: By Drug Type: By Drug Type: Antifungal- Antifungal- ● ● Voriconazole Voriconazole ● ● Capsofungin Capsofungin ● ● Itraconazole Itraconazole ● ● Isavuconazole Isavuconazole ● ● Corticosteroids- Corticosteroids- Prednisolone Prednisolone ● ● Prednisone Prednisone ● ● Methylprednisolone Methylprednisolone ● ● Request for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/1520 Request for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/1520 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Acute Invasive Aspergillosis Treatment Market: Key Players GlaxoSmithKline. ● Mylan Pharmaceuticals, Inc. ● Novartis AG. ● Abbott laboratories. ● Eli Lilly and Company. ● AstraZeneca Plc. ● Pfizer, Inc.. ● Johnson & Johnson. ● Takeda Pharmaceutical Company Ltd. ● View this report @ https://www.coherentmarketinsights.com/ongoing-insight/acute-invasive-aspergillosis-treatment-market-1520 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES Chemicals & Materials Speciality and Fine Chemicals Advanced Materials Bulk Chemicals Green Chemicals Polymers & Resins Food Ingredients Cosmetic Ingredients © Coherent market Insights. All Rights Reserved

  7. ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARC H EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. T o know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentm arketinsights.com THANK YOU For other queries contact: Mr. Shah (M anager - Business Development) C oherent Market Insights sales@coherentm arketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related